Journey Medical Corp
DERM
Get informed when a big investor buys or sells
+ FollowMarket Cap$184.95M
Close$
$-5.57
183.7% downside
Current Fair Value
183.7% downsideOvervalued by 183.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $184.95 Million |
|---|---|
| Enterprise Value | $184.84 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 1.08 |
| Outstanding Shares | 27,493,693 |
Return
| Return on Equity | -19.01% |
|---|---|
| Return on Assets | -6.21% |
| Return on Invested Capital | -7.21% |
Valuation & Multiples
| P/E Ratio | -29.75 |
|---|---|
| PEG | 32.41 |
| Price to Sales | 3.33 |
| Price to Book Ratio | 6.65 |
| Enterprise Value to Revenue | 2.71 |
| Enterprise Value to EBIT | -48.75 |
| Enterprise Value to Net Income | -31 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$18.36 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$0.01
Average shareholder expectationRevenue Estimate
$21.89 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 12.47%▼ 30.94% |
|---|---|
| Total Invested | $24.11M▼ 56.73% |
| Investors Holding | 19▼ 53.00% |
ESG Score
No data